NI
BMRN icon

Numeric Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Numeric Investors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$972K Sell
10,900
-27,400
-72% -$2.38M 0.01% 753
2017
Q3 		$3.56M Buy
38,300
+22,200
+138% +$1.96M 0.03% 477
2017
Q2 		$1.46M Buy
16,100
+10,100
+168% +$919K 0.01% 586
2017
Q1 		$527K Buy
6,000
+2,900
+94% +$258K ﹤0.01% 780
2016
Q4 		$257K Sell
3,100
-18,300
-86% -$1.57M ﹤0.01% 953
2016
Q3 		$1.98M Buy
21,400
+7,700
+56% +$725K 0.02% 472
2016
Q2 		$1.07M Buy
+13,700
New +$1.16M 0.01% 568
2015
Q3 		– Sell
-8,600
Closed -$1.18M – 990
2015
Q2 		$1.18M Buy
8,600
+6,800
+378% +$843K 0.01% 471
2015
Q1 		$224K Sell
1,800
-262,400
-99% -$27.8M ﹤0.01% 790
2014
Q4 		$23.9M Buy
+264,200
New +$22M 0.31% 75
2014
Q3 		– Sell
-6,100
Closed -$379K – 819
2014
Q2 		$379K Buy
+6,100
New +$369K 0.01% 621
2014
Q1 		– Sell
-18,000
Closed -$1.27M – 787
2013
Q4 		$1.27M Buy
18,000
+13,400
+291% +$910K 0.02% 425
2013
Q3 		$332K Sell
4,600
-31,500
-87% -$2.09M 0.01% 648
2013
Q2 		$2.01M Buy
+36,100
New +$2.25M 0.04% 311

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Numeric Investors's BMRN Position: Q4 2017 in Review

Numeric Investors reduced its BioMarin Pharmaceuticals (BMRN) stake by 72% in Q4 2017, selling an estimated $2.38M and leaving 10,900 shares worth $972K. The position accounts for 0.01% of the portfolio, ranked #753.

Numeric Investors first reported a position in BMRN in Q2 2013 and has held it in 14 quarters since. The position peaked at $23.9M in Q4 2014. 438 funds tracked by Wall St. Rank hold BMRN as of Q4 2017.

  • Numeric Investors held 10,900 shares of BioMarin Pharmaceuticals worth $972K as of Q4 2017.
  • Numeric Investors sold 27,400 BioMarin Pharmaceuticals shares in Q4 2017, an estimated $2.38M.
  • BioMarin Pharmaceuticals made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #753 holding.
  • Numeric Investors first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • Numeric Investors's BioMarin Pharmaceuticals position peaked at $23.9M in Q4 2014.
  • 438 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.